Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, Other products), By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB), By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells), By Molecule (Mon
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSingle-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, Other products), By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB), By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells), By Molecule (Mon
In January 2022, HaemaLogiX Ltd (HaemaLogiX) and Lonza entered into an agreement for manufacturing the next clinical batch (cGMP) of HaemaLogiX’s lead multiple myeloma drug candidate and KappaMab, which is a monoclonal antibody and binds to a cell surface target which is called as kappa myeloma antigen (KMA) and found on myeloma cancer cells and not on normal plasma cells.
Increasing demand for biopharmaceuticals
Biopharmaceuticals play a significant role in driving the growth of the Global Single-Use Bioreactors Market. Biopharmaceuticals are drugs and vaccines that are produced using living organisms such as bacteria, yeast, or mammalian cells. Single-use bioreactors are widely used in the production of these biopharmaceuticals due to their cost-effectiveness, efficiency, and flexibility.
Cost-effectiveness and efficiency of single-use bioreactors
Cost-effectiveness and efficiency are key factors driving the growth of the Global Single-Use Bioreactors Market. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of cost and efficiency.
Download Free Sample ReportGrowing focus on personalized medicine
Personalized medicine is a major driver of the growth of the Global Single-Use Bioreactors Market. Personalized medicine is an approach to healthcare that considers individual variability in genes, environment, and lifestyle when designing treatment plans for patients. This approach requires the production of targeted and individualized therapies, which can be achieved using biopharmaceuticals and single-use bioreactors.
Single-use bioreactors are particularly well-suited to produce smaller batches of biopharmaceuticals, which are often required for personalized medicine. They are ideal for research and development purposes, as they allow for rapid and cost-effective testing of new therapies.
Advancements in bioprocessing technology
Advancements in technology and research are key drivers of the growth of the Global Single-Use Bioreactors Market. As the biopharmaceutical industry continues to evolve and expand, there is a growing need for more efficient and cost-effective bioprocessing solutions.
Growing funding for the biopharmaceutical industry
Growing government support play a significant impact on the growth of the Global Single-Use Bioreactors Market. Governments around the world are increasingly recognizing the importance of the biopharmaceutical industry and the role of these bioprocessing technologies, such as single-use bioreactors, play an important role in the development and production of biopharmaceutical products such as novel drugs.
Recent Development
- In March 2022, Sartorius AG announced the launch ofits new single-use bioreactor system, BIOSTAT STR® 1000. The system was designedto meet the growing demand for large-scale bioprocessing and offers advancedautomation and control features.
- In January 2022, GE Healthcare Life Sciences announcedthe acquisition of Univercells Technologies, a provider of innovativebioprocessing solutions. The acquisition is expected to expand GE Healthcare'sofferings in the single-use bioreactors market and enhance its position in thebiopharmaceutical industry.
- In December 2021, Thermo Fisher Scientific announcedthe launch of its new single-use bioreactor, the HyPerformaâ„¢ Single-UseBioreactor (SUB). The system is designed to provide high yields and processefficiencies, with improved flexibility and scalability.
- In November 2021, Merck KGaA announced the expansionof its single-use manufacturing facility in the United States. The expansion isexpected to increase Merck's capacity to produce single-use bioreactors and supportthe growing demand for biopharmaceutical products.
- In September 2021, Pall Corporation announced thelaunch of its new single-use bioreactor, the Allegroâ„¢ STR 400. The systemoffers advanced automation and control features, as well as improved flexibilityand scalability for bioprocessing operations.
Market Segmentation
Global Single-Use Bioreactors market can be segmented by product, type, type of cell, molecule, application, usage, end user and by region. Based on product, the market can be segmented into Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products. Based on type, the market can be segmented into Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB. Based on type of cell, the market can be differentiated into Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells. Based on molecules, the market can be grouped into Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules. Based on application, the market can be segmented into Research and Development, Bioproduction. Based on usage, the market can be differentiated into Lab scale production, Pilot scale production, large scale production. Based on end user, the market can be grouped into Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes.
Market Players
ABEC,INC.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Product By Type By Type of Cell By Molecule By Application By Usage By End User By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key companies profiled | ABEC,INC., Able Corporation & Biott Corporation., BBI-Biotech Gmbh., Cellexus Biosystems PLC., Celltainer Biotech BV., Danaher Corp., Distek Inc., Eppendorf AG., G&G Technologies, Inc. , Getinge AB |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy